Product Information
BROMFENAC SOD 0.075% EYE DROP is a generic product labeled by Sun Pharmaceutical Industries Inc., priced at $24.3848 per ML under NDC 49708075541. Its NADAC has been published 124 times since May 22, 2024.
FDA first approved this application on Apr 8, 2016. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
.76 mg/mL
Manufacturer
Sun Pharmaceutical Industries Inc.NDC
49708075541
Classification
Generic
Dosage Form
SOLUTION/ DROPS
Route
OPHTHALMIC
Effective Date
9/23/2026
Active Ingredients
BROMFENAC SODIUMApproval Type
Authorized Generic (NDA)
FDA Application
NDA206911FDA Approved
4/8/2016
TE Code
AB
On Market Since
2/7/2024
Pharmacological Classes
Price Statistics
The NADAC for BROMFENAC SOD 0.075% EYE DROP has been published 124 times since May 22, 2024, and over the history we have for it it has declined 2.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $24.3848 per ML |
|---|---|
| All-time high | $26.7005 (Mar 11, 2026) |
| All-time low | $19.7579 (Dec 18, 2024) |
| 52-week high | $26.7005 |
| 52-week low | $23.5416 |
| Median price | $24.0979 |
| Average price | $23.6806 |
| Largest weekly change | -22.0% (Jul 17, 2024) |
| Weeks tracked | 124 |
| Tracking since | May 22, 2024 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Sun Pharmaceutical Industries Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
bromfenac market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Nonsteroidal Anti-inflammatory Drug class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of BROMFENAC SOD 0.075% EYE DROP?
The current National Average Drug Acquisition Cost (NADAC) for BROMFENAC SOD 0.075% EYE DROP, manufactured by Sun Pharmaceutical Industries Inc., is $24.3848 per ML (NDC 49708075541), effective Sep 30, 2026.
How has the price of BROMFENAC SOD 0.075% EYE DROP changed over time?
Over the history we have for it, the NADAC for BROMFENAC SOD 0.075% EYE DROP has declined 2.9%. It has been tracked across 124 weekly CMS publications since May 22, 2024.
What are the highest and lowest recorded NADAC prices for BROMFENAC SOD 0.075% EYE DROP?
Since May 22, 2024, the NADAC for BROMFENAC SOD 0.075% EYE DROP has ranged from a low of $19.7579 (Dec 18, 2024) to a high of $26.7005 (Mar 11, 2026), with a median of $24.0979 per ML.
Are there cheaper alternatives to BROMFENAC SOD 0.075% EYE DROP?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as BROMFENAC SOD 0.075% EYE DROP in a comparable dosage form, but none are currently priced below it.
Who manufactures BROMFENAC SOD 0.075% EYE DROP?
BROMFENAC SOD 0.075% EYE DROP (NDC 49708075541) is labeled by Sun Pharmaceutical Industries Inc., and CMS classifies it as a generic product.